E-cigarette vapor contains more carcinogenic formaldehyde than regular cigarettes
the ONA take:
E-cigarette vapor may contain cancer-causing formaldehyde at a level 15 times higher than normal cigarettes, according to a new study published in the New England Journal of Medicine.
“We’ve found that there is a hidden form of formaldehyde in e-cigarette vapor that has not typically been measured,” said James Pankow, PhD, co-author of the study along with fellow researchers at Portland State University in Oregon. “People shouldn’t assume these e-cigarettes are completely safe.”
While once believed to be a less harmful alternative to the formaldehyde and toxic chemicals found in the smoke of normal cigarettes, newer e-cigarettes operate at high temperatures that dramatically boost the creation of formaldehyde-containing compounds.
The researchers found that, at high voltage, formaldehyde-releasing agents in e-cigarettes increased a person’s lifetime risk of cancer by five-to-15 times greater than the risk of long-term smoking with regular cigarettes. However, the compounds were not found when they were operated at a lower voltage.
The American Vaping Association, an advocacy group for e-cigarette makers, criticized the study, stating that users wouldn’t normally operate devices at such a high voltage.
E-cigarettes remain unregulated, and representatives from the American Cancer Society stated that the findings from the study stress the importance of FDA oversight.
E-cigarette vapor may contain cancer-causing formaldehyde at a level 15 times higher than normal cigarettes.
- Ixazomib, a New PI, Offers Improved Efficacy With Acceptable Toxicity Profile for Relapsed/Refractory Multiple Myeloma
- Acupuncture May Improve Fatigue in Patients with Lung Cancer
- "Light" Cigarettes and Cancer Risk (Fact Sheet)
- A Review of CDK4/6 Toxicities and Interactions Management in Breast Cancer
- Vitamin D3 Supplementation Has No Impact on Breast Density Percentage, Breast Cancer Risk
- Dexamethasone-Induced Hiccups in Chemotherapy May be Prevented by Rotating to Methylprednisolone
- New Evidence Shows Metastases May Spread Independently of Lymph Nodes
- Long Term Survivors of Prostate Cancer Express Treatment Decision Regret for Up to 15 Years
- FDA Expands Clearance for Cooling Cap Use With Chemotherapy for Solid Tumors
- Recommendations for Vaccine Administration During Chemotherapy
- Palliative Cancer Care Should Focus on Symptoms, Not Diagnoses
- COX-2 Inhibitors Can Improve Response to Immunotherapy of Some Cancer Tumors
- Risk for Prostate Cancer Not Associated With Vasectomy, Meta-analysis Affirms
- Disease-Free Survival After Breast Cancer Comparable With Exemestane, Sequential Tamoxifen/Exemestane
- Treating the Other "Patient": Depressive Symptoms Are Predictive of Declining Physical Health in Caregivers
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|